Growth Metrics

Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025)

Invivyd posted quarterly Other Accumulated Expenses of $52000.0 for Q4 2025, up 92.59% year-on-year from $27000.0 in Q4 2024, and up 62.5% on a QoQ basis from $32000.0 in Q3 2025.

Invivyd (IVVD) has 4 years of Other Accumulated Expenses data on file, last reported at $52000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 92.59% year-over-year to $52000.0; the trailing twelve-month figure through Dec 2025 stood at $52000.0 (up 92.59% YoY), and the FY2025 full-year result was $52000.0, up 92.59% from the prior year.
  • Other Accumulated Expenses for Q4 2025 stood at $52000.0, up from $32000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $58000.0 in Q2 2022 and bottomed at $20000.0 in Q3 2024.
  • The 4-year median for Other Accumulated Expenses is $35000.0 (2023), against an average of $37666.7.
  • The widest annual swing landed in 2023, when Other Accumulated Expenses plunged 49.06%; it then surged 92.59% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $44000.0 in 2022, then retreated by 20.45% to $35000.0 in 2023, then dropped by 22.86% to $27000.0 in 2024, then soared by 92.59% to $52000.0 in 2025.
  • The last three Other Accumulated Expenses figures came in at $52000.0 (Q4 2025), $32000.0 (Q3 2025), and $26000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Invivyd 208.38 Mn -18.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 52,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 34,000.00
Dec 31, 2024 27,000.00
Sep 30, 2024 20,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 27,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 44,000.00
Sep 30, 2022 53,000.00
Jun 30, 2022 58,000.00